Protocol No
FH-COG-ARST2031
Phase
III
Summary
This study looks at how well the two different chemotherapy regimens work when given to children and adults with high risk RMS disease. Adding vinorelbine to one of the chemotherapy regimens is experimental because it has not been proven to work in a situation like yours. Although use of vinorelbine is being investigated for use in high risk RMS, this drug has been approved for other uses. Vinorelbine has been shown to be well-tolerated in children and adults with RMS that is not high risk, and has been used for other types of cancers.
Description
A Study to Compare Early Use of Vinorelbine and Maintenance Therapy for Patients with High Risk Rhabdomyosarcoma.
Participating Institutions
Froedtert Hospital
Status
OPEN TO ACCRUAL
ClinicalTrials.gov